Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease - Wikidata - wikimedia - TriplyDB

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

http://www.wikidata.org/entity/Q36953075

about

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's disease Clinical and research applications of simultaneous positron emission tomography and MRI Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study.How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.Interaction between years of education and APOE ε4 status on frontal and temporal metabolism.Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease.Role of Educational Status in Explaining the Association between Body Mass Index and Cognitive Function Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve.Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory.Cognitive reserve and Alzheimer's disease.Life-course determinants of cognitive reserve (CR) in cognitive aging and dementia - a systematic literature review.Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.Asymptomatic Alzheimer disease: Defining resilience.Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.Implementation of subjective cognitive decline criteria in research studies.Resting-State Connectivity of the Left Frontal Cortex to the Default Mode and Dorsal Attention Network Supports Reserve in Mild Cognitive Impairment.The BDNF Val66Met polymorphism moderates the effect of cognitive reserve on 36-month cognitive change in healthy older adults.The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease.Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.The Impact of Age and Cognitive Reserve on Resting-State Brain Connectivity.Multiple pathways of reserve simultaneously present in cognitively normal older adults.Differential age-related gray and white matter impact mediates educational influence on elders' cognition.The left frontal cortex supports reserve in aging by enhancing functional network efficiency.Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study.An Algorithm for Preclinical Diagnosis of Alzheimer's Disease.The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis

P2860

Q26796235-BE385EE6-264A-4415-9E88-B52E0798120B Q26998774-6CB92512-815D-4F0A-81FF-9265F2321DAA Q30580439-8A04BF2A-A8D7-4707-9143-E90E76F60F72 Q30971403-6C7662CE-AEB6-4754-B267-B934A919AD81 Q31114398-6EAD4AF3-5A21-40A7-B1A5-DA69A23747AE Q33606033-3BD99382-FD16-4A89-B513-985E9FE0922F Q35660011-54A84573-28C2-437E-A246-35A4FED93FD2 Q36225119-7CDD1A71-03E6-4CCE-9E63-B6B9BA5BA4EE Q36265279-6CB713F6-6D0C-41D4-B8E4-59E93FF5FB32 Q36457301-91B213DB-5BD9-40D2-839E-E2CED03FF3C4 Q36566909-B8B31B7C-0F60-4549-995C-64EBCE6C645D Q37295601-DF2E181E-0971-4256-9558-1500135E05A8 Q37343322-1B7E12C6-8F8A-4E6B-AEF8-1D4B6F1C73BC Q37725644-422EC27E-68F2-4DF6-A7A1-D33BA1EAF928 Q38209190-1609ED8A-173A-49D2-BE84-6BC9EE582284 Q38681421-5BC25D1A-5629-4E09-A4FF-CE854017878A Q38704916-0AD43A93-B928-4E84-BEBE-A7C77F614DA5 Q39299268-94CAEF3C-D297-45D2-8367-EEDC32895C94 Q40032141-2958E697-08CB-46DE-B73B-BBE7426520F6 Q40153300-B65D3C5F-3626-4B03-BF7D-B9CC170A5C9B Q40483941-C1E79906-0E60-471C-8D5F-3F819FEF84D7 Q41269754-7FCE136B-8108-4B39-B1DB-D033C8075904 Q42655796-09FCB13E-530A-4789-8EA5-3A37C76B93E5 Q42689647-BDB220AD-8E25-4EE4-90F7-1852B6C580F8 Q46206017-5BDACC8E-E893-4960-8D91-F7215A78C367 Q47100334-0365694F-1F6C-4220-8F52-BF5E083016C2 Q47898489-433CBF40-F6FD-4DCF-AAA6-2B4C727673A0 Q48565026-C1D5E978-3359-46C5-8459-EBBD79C6081D Q50420643-EA1D5AD2-79BA-4357-94F5-4678436F1876 Q50535708-9779592C-2739-4548-B3C3-7348756BDC8B Q52147449-B05400EC-8D23-4691-97B5-93B835DCA3FC Q52609373-411F3ADF-B567-42E8-B28A-8FBACD6BF037 Q52644606-D31C5467-9279-4FB0-9D09-FAFFEB5EBB9C Q53090438-E71780B2-20B2-4680-9794-59F90E518E02 Q55146345-2341B706-06D6-42DB-84EB-E5A2B8F42D74 Q59128736-ED805698-07AB-4E9B-B26C-50F048543BA2

P2860

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

http://www.wikidata.org/entity/Q36953075

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

@en

type

label

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

@en

prefLabel

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

@en

P1433

Q36953075-FC84E97F-4E7B-41E8-8E43-3BE8D7FEAB0A

P1476

Q36953075-3D342703-439E-4888-8BFD-4C168C31EE08

P2093

Q36953075-71EC2355-5924-4801-A8E1-88B9F8C7B504

Q36953075-7E2BF448-2392-4D9D-8CC9-2FC6BE19A18E

P2860

Q36953075-0C385D51-100B-4383-A4BD-254B630FC0AE

Q36953075-12AAD583-1E3F-42A1-BABF-EE1665553DDF

Q36953075-1B8CC213-ECE7-4C76-9A46-51B4588256ED

Q36953075-1E86981A-5A3D-49BB-8B93-FA2FDE67F09B

Q36953075-1EF8D68D-8976-4644-AD74-92A1F5F5F426

Q36953075-25EAE985-18B4-4E18-9DED-73843BF509C6

Q36953075-2F7964C5-281C-43F5-B97C-DC086E3EC41C

Q36953075-3352E6E2-F046-400B-94A6-0511DDB14607

Q36953075-35A8C84B-9EAA-4E74-A796-38AF530462EC

Q36953075-39067A52-3FB1-4AEE-AA38-A0B59A887C52

P304

Q36953075-E93EE848-7F1C-48E7-9DF4-283CC2835736

P31

Q36953075-36B75801-3622-4464-ADA5-FC3731948FA1

P356

Q36953075-85168CFB-EC49-4BC3-A04D-EC3229018F4C

P407

Q36953075-58838165-8BF0-47EB-A098-2FDFA32CBF5F

P433

Q36953075-38D19F56-F125-401A-A542-D84B193FE49E

P478

Q36953075-CEAAFC40-39AA-4C67-9F32-470A982993D4

P50

Q36953075-6C514C45-405D-4035-A326-AFDED22BB710

Q36953075-7588E125-3C85-4CAE-A627-A3A504653C78

Q36953075-89368C80-EEFA-4A42-927F-2B9FBEA39923

P577

Q36953075-5AAA7FB5-7B4B-4546-8EF9-0D1587B88B43

P698

Q36953075-D3D4D111-2544-4BB2-87CA-02EDB519C145

P921

Q36953075-7C031121-055C-468D-962D-FD2685EE1390

P932

Q36953075-8B4F93C3-9795-4E6E-87F2-4FD59BE00ED0

P356

WNL.0B013E31828970C2

P1433

P1476

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

@en

P2093

Michael Ewers

http://www.w3.org/2001/XMLSchema#string

Philip S Insel

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

What is cognitive reserve? Theory and research application of the reserve concept

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Cognitive reserve.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease.

P304

1194-1201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31828970C2

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner

P577

2013-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23486873

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3691784

http://www.w3.org/2001/XMLSchema#string